Collectively, the results of the present studies buttress the connections between RAGE and DIAPH1 and suggest that blockade of RAGE/DIAPH1 may be a key adjunctive strategy in therapeutic approaches to atherosclerosis, at least in part through regulation of lipid metabolism. The gene discussed is DIAPH1; the disease is atherosclerosis.